BioDiscovery

The companies will join their respective technologies to offer customers a single solution for next-generation sequencing data interpretation.

The software allows researchers to visualize copy number variation, absence of heterozygosity, and single nucleotide variations.

The deal provides customers a complete end-to-end solution for cytogenomic array and next-generation sequencing services, the firms said.

NEW YORK (GenomeWeb) –Life science software firm BioDiscovery this week unveiled NXClinical, a new addition to its product portfolio that's tailored specifically for the clinical laboratory market and provides tools for analyzing, processing, and reporting the results of genetic tests.

NEW YORK (GenomeWeb) – Genomic analysis software maker BioDiscovery said today it will use a $157,000 grant from the National Cancer Institute to analyze and improve copy number variant data from The Cancer Genome Atlas program.

Innopsys has launched its newest microarray scanner, the InnoScan 910 microarray scanner. The two-color fluorescence scanner is capable of reading high-density microarrays with a resolution of 1 micron per pixel.

NantHealth said this week that it has launched a fully integrated genomic and transcriptomic analytic engine that can identify mutations such as copy number variants and genomic rearrangements in DNA, RNA, and protein pathways accurately and efficiently.

NEW YORK (GenomeWeb News) – BioDiscovery and N-of-One today announced a marketing agreement to provide genomic analysis interpretation solutions.

GenBank 200.0 is now available from the National Center for Biotechnology Information via ftp.

Affymetrix and BioDiscovery this week announced the availability of Nexus for OncoScan Software for the analysis of whole-genome copy number data generated from formalin-fixed, paraffin-embedded solid tumor samples using Affy's OncoScan FFPE Expr

Pages

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.